Ribosome profiling:
Unlocking the translational landscape

OHMX.bio stands as a global leader in ribosome profiling (RIBO-seq), offering cutting-edge solutions that provide unparalleled insights into the dynamics of protein synthesis. Our proprietary, high-performance pipeline and deep scientific expertise enable researchers to move beyond transcriptomics, directly observing the translational landscape with exceptional precision and reliability. We are committed to delivering the most accurate and insightful translatomics data to accelerate your discoveries across all areas of life science research.

What is Ribosome profiling?

Ribosome profiling (RIBO-seq) is a powerful next-generation sequencing technique that captures ribosome-protected mRNA fragments (RPFs). By precisely mapping the positions of active ribosomes on mRNA molecules, RIBO-seq offers a real-time, genome-wide snapshot of translation. This innovative technology bridges the critical gap between mRNA abundance (transcriptomics) and protein expression (proteomics), revealing crucial regulatory mechanisms that cannot be discerned from RNA sequencing alone, such as translational control, ribosome occupancy, and the identification of novel open reading frames (ORFs).

The OHMX.bio advantage: Unparalleled precision and insight

Our world-renowned expertise in ribosome profiling is built upon a foundation of proprietary methodologies and a relentless commitment to scientific excellence:

Superior Methodology

OHMX.bio utilizes a proprietary, high-performance pipeline meticulously optimized for RIBO-seq. This includes an industry-leading rRNA depletion strategy that ensures the highest signal-to-noise ratio, providing the most precise and reliable translatomics data available.

Tailored Solutions for Diverse Research Objectives

We offer distinct RIBO-seq solutions designed to address specific scientific questions:

Unparalleled Bioinformatics Expertise

Our services are complemented by two advanced bioinformatics packages, each meticulously tailored to support our RIBO-seq pipelines. With years of experience handling diverse data types and visualizations, our team ensures accurate, reproducible results and helps you extract the most value from your sequencing data, delivering high-quality interpretations for informed decision-making.

Broad Sample Compatibility

OHMX.bio has successfully optimized its ribosome profiling protocols across a wide range of challenging sample types, including various cell lines (adherent and suspension), diverse tissue samples (frozen and fresh), liquid biopsies, and even plant-derived samples. We provide detailed guidelines for sample preparation, including ribosomal stalling protocols, to guarantee high-quality RPF isolation.

OHMX.bio - Innovative omics solutions
OHMX.bio_Innovative omics solutions_Scientific Excellence

Applications across all types of research

Ribosome profiling offers transformative insights across a vast array of research fields, making it an indispensable tool for understanding gene expression and its regulation:

Disease Mechanisms

Uncover translational dysregulation in conditions such as cancer, neurodegenerative disorders, and metabolic diseases.

Drug Development

Evaluate gene expression changes in response to drug candidates at the translational level, aiding in mechanism-of-action studies and identifying novel therapeutic targets.

Biomarker Discovery

Identify novel translation-based biomarkers for disease diagnostics, prognosis, and patient stratification.

Translational Control

Gain deep insights into how translation is regulated, including the roles of microRNAs, RNA-binding proteins, and various initiation and termination mechanisms.

Functional Genomics

Precisely define protein-coding regions and discover novel peptides, expanding the functional annotation of genomes.

Case studies

Case study 1: Decoding sites of RNA translation in normal and cancerous tissues

Understanding the precise locations of active RNA translation is critical for deciphering gene regulation and identifying potential therapeutic targets, especially in complex diseases like cancer.
In a groundbreaking study titled “Deep learning to decode sites of RNA translation in normal and cancerous tissues” (Clauwaert, J., McVey, Z., Gupta, R. et al., Nat Commun 16, 1275 (2025)), OHMX.bio played a pivotal role in advancing this understanding. This research leveraged deep learning approaches combined with RIBO-seq data to accurately map translation initiation sites and identify actively translated regions across various tissues. The study provided unprecedented resolution into the translational landscape, revealing distinct patterns in cancerous versus normal tissues. This capability is vital for identifying novel cancer-specific translational signatures, understanding how tumors hijack translational machinery, and ultimately, for developing new therapeutic strategies that target these mechanisms. OHMX.bio’s expertise in generating high-quality RIBO-seq data was instrumental in enabling the sophisticated computational analyses that led to these significant findings.

Case study 2: Characterization of shared neoantigens in mismatch repair deficient endometrial cancer

Neoantigens, unique peptides presented on the surface of cancer cells, are crucial targets for cancer immunotherapies. Their accurate identification is paramount for developing effective personalized treatments.
In the study “Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer” (De Paolis, E., Nero, C., Micarelli, E. et al., npj Precis. Onc. 8, 283 (2024), DOI: 10.1038/s41698-024-00779-4), OHMX.bio’s ribosome profiling expertise contributed significantly to characterizing the neoantigen landscape in Mismatch Repair Deficient (MMRd) Endometrial Cancer. By combining genomic data with RIBO-seq, the researchers were able to identify actively translated neoantigens, providing a more refined list of immunogenic targets compared to predictions based solely on DNA or RNA sequencing. This is because RIBO-seq directly confirms which mutated sequences are actually being translated into proteins that can be presented to the immune system. This study underscores the power of RIBO-seq in the field of immuno-oncology, enabling the precise identification of shared neoantigens that could be exploited for the development of novel, broadly applicable immunotherapies for patients with MMRd endometrial cancer.

Partner with OHMX.bio for your translational research

With a foundation in ribosome profiling and a track record of numerous peer-reviewed publications, OHMX.bio is the trusted expert in translatomics. Our proprietary methodologies, deep bioinformatics expertise, and commitment to scientific excellence ensure that you receive the most accurate and insightful RIBO-seq data for your cutting-edge research.

Contact OHMX.bio today to discuss your ribosome profiling needs and take your translational research to the next level.
OHMX.bio_Innovative omics solutions_Tailored Personal Approach

Let’s get in touch!

Are you curious about how we can work on your -omics challenges together? Fill out the form below!
Our experts will reply within 2 working days to freely discuss your omics project.

Our publications using our cell en gene therapies

  1.  
Logo-OHMX.bio
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Cookie statement

Last updated:  19-09-2024

This cookie statement is drafted and managed by OHMX.bio NV,

hereafter referred to as “OHMX.bio”.

OHMX.bio has its headquarters at Proeftuinstraat 86, 9000 Gent, Belgium, registered with company number XXX.

For all questions and/or remarks, please contact us at the address mentioned above or at the e-mail address privacy@ohmx.bio.

USE OF COOKIES

 

OHMX.bio considers it important that you can view, listen to, read or experience our website content at any place and at any time via various media platforms. We want you to be able to use interactive features and provide services tailored to your needs. Therefore OHMX.BIO uses online techniques like cookies, scripts and similar technologies (hereafter referred to as ‘cookies’). These help us facilitate the use of the website and improve its functionality, by collecting (personal) data of our website visitors via their website usage.

 

In this cookie statement, OHMX.bio wishes to inform you what kind of cookies are used and why.

OHMX.bio can amend the cookie statement at any time. This can happen, for example, in the context of changes to its services or the applicable legislation. The amended statement will then be published on the OHMX.bio websites and will apply from the moment it is published.

 

If the use of certain cookies also involves the processing of “personal data”, the OHMX.bio Privacy Statement is also applicable.

 

WHAT ARE COOKIES?

 

A cookie is a small data file that is installed in the browser of your computer or mobile device by a website's server or application when you visit a website or use a (mobile) application.

The cookie file contains a unique code with which your browser can be recognized during the visit to the online service or during consecutive, repeated visits. They generally make the interaction between the visitor and the website or application easier and faster and help the visitor to navigate between the different parts of a website or application. They allow us to retain certain settings, such as your language choice or to optimize your user experience.

 

There are different types of cookies that can be distinguished according to their origin, function and lifespan. This is explained further in the next section.

TYPES OF COOKIES

How long are cookies stored?

Cookies can be stored on your computer or mobile device for different periods of time. Depending on the type, they (and the information they collect) are automatically deleted when you close your browser (these are the so-called “session cookies”), in other cases, these remain stored for a longer period of time and can also be used during a subsequent visit to this website (these are the so-called “permanent cookies”).

Consult the detailed information on OHMX.bio cookies (below) to know the retention periods.

Who places and manages cookies?

First-party cookies

First-party cookies are managed by OHMX.bio and are specific to the visited or used online service.

Third party cookies

Third party cookies are managed and placed by a third party. This happens during your visit or use of the website. These ensure that certain information is sent to third parties by your visit to the website.

Why cookies?

Necessary cookies

Necessary or essential cookies are necessary for the operation of the website. It is therefore advised not to disable these.

Functional cookies

These are cookies that ensure that the website functions properly. Examples of some functions performed:

- remembering your login details

- ensuring the security of your login details

- ensuring the uniformity of the layout of the website

Performance and analysis cookies

On the basis of these cookies, information is collected about the way visitors use our website. This is done with the intention to improve the content of our websites, to further adapt it to the wishes of the visitors and to increase the usability of our websites. Like for example google analytics.

Social media cookies

The website can implement so-called embedded elements of other third parties, such as YouTube, Twitter and Facebook. These are used to integrate social media into the website via plug-ins.

Other cookies

These are cookies that do not belong to one of the above categories. For example, cookies that can be used to make web analyzes themselves to optimize the website. In addition to the above-mentioned performance and analysis cookies, other web analysis cookies can be used. These will probably have to be disabled because identifiable personal data may be processed here. This is not the case with the mentioned performance analysis cookies.

OHMX.bio  uses different types of cookies.

 

Cookie Description Duration Type
cookielawinfo-checkbox-necessary This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". 1 hour Necessary
__utma This cookie is set by Google Analytics and is used to distinguish users and sessions. The cookie is created when the JavaScript library executes and there are no existing __utma cookies. The cookie is updated every time data is sent to Google Analytics. 2 years Performance
__utmc The cookie is set by Google Analytics and is deleted when the user closes the browser. The cookie is not used by ga.js. The cookie is used to enable interoperability with urchin.js which is an older version of Google analytics and used in conjunction with the __utmb cookie to determine new sessions/visits. Performance
__utmz This cookie is set by Google analytics and is used to store the traffic source or campaign through which the visitor reached your site. 5 months Performance
__utmt The cookie is set by Google Analytics and is used to throttle request rate. 10 minutes Performance
__utmb The cookie is set by Google Analytics. The cookie is used to determine new sessions/visits. The cookie is created when the JavaScript library executes and there are no existing __utma cookies. The cookie is updated every time data is sent to Google Analytics. 30 minutes Performance

 

HOW CAN YOU TURN OFF COOKIES?

 

If you choose to disable cookies, you can do so for the browser you use:

 

If you use different devices to visit this website, make sure that your cookie preferences are set on the browser of every device.

 

Please note that disabling certain cookies may result in the malfunction of related features on the website e.g. certain graphics may not show the way they are meant to, or you may not be able to use certain services.

CHANGES TO THIS COOKIE STATEMENT

OHMX.BIO may amend this Cookie Statement in accordance with certain technical, legal or commercial requirements and developments. We will inform you accordingly, taking into account the importance of the changes that have been made. You may find the date on which this Cookie Statement was last modified at the top of this Cookie Statement.